132 related articles for article (PubMed ID: 35768004)
1. [Radioiodine testing in clinical routine: Status in Germany 2021].
Akbarzadeh Taghavi P; Fabiunke T; Brenner W
Nuklearmedizin; 2022 Oct; 61(5):367-375. PubMed ID: 35768004
[TBL] [Abstract][Full Text] [Related]
2. [Guideline for Radioiodine Therapy for Benign Thyroid Diseases (6/2022 - AWMF No. 031-003)].
Dietlein M; Grünwald F; Schmidt M; Kreissl MC; Luster M; ; ; ;
Nuklearmedizin; 2024 Feb; 63(1):8-20. PubMed ID: 37871629
[TBL] [Abstract][Full Text] [Related]
3. Follow-up on thyroidal uptake after radioiodine therapy: how robust is the peri-therapeutic dosimetry?
Eschner W; Kobe C; Schicha H
Z Med Phys; 2011 Dec; 21(4):258-65. PubMed ID: 21719262
[TBL] [Abstract][Full Text] [Related]
4. Correction for hyperfunctioning radiation-induced stunning (CHRIS) in benign thyroid diseases.
Happel C; Kranert WT; Gröner D; Bockisch B; Sabet A; Vardarli I; Görges R; Herrmann K; Grünwald F
Endocrine; 2020 Aug; 69(2):466-473. PubMed ID: 32173798
[TBL] [Abstract][Full Text] [Related]
5. The EANM guideline on radioiodine therapy of benign thyroid disease.
Campennì A; Avram AM; Verburg FA; Iakovou I; Hänscheid H; de Keizer B; Petranović Ovčariček P; Giovanella L
Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3324-3348. PubMed ID: 37395802
[TBL] [Abstract][Full Text] [Related]
6. [Exposure of relatives of patients after stationary radioiodine therapy by inhalation of 131I in their homes].
Wellner U; Eschner W; Hillger HW; Schicha H
Nuklearmedizin; 1998 May; 37(3):113-9. PubMed ID: 9604232
[TBL] [Abstract][Full Text] [Related]
7. [Radioiodine therapy for benign thyroid diseases (version 5). German Guideline].
Dietlein M; Grünwald F; Schmidt M; Schneider P; Verburg FA; Luster M
Nuklearmedizin; 2016 Dec; 55(6):213-220. PubMed ID: 27922153
[TBL] [Abstract][Full Text] [Related]
8. Combination of ultrasound guided percutaneous microwave ablation and radioiodine therapy in benign thyroid diseases. A suitable method to reduce the 131I activity and hospitalization time?
Happel C; Korkusuz H; Koch DA; Grünwald F; Kranert WT
Nuklearmedizin; 2015; 54(3):118-24. PubMed ID: 25586901
[TBL] [Abstract][Full Text] [Related]
9. Radioiodine therapy in benign thyroid disorders. Evaluation of French nuclear medicine practices.
Bernard D; Desruet MD; Wolf M; Roux J; Boin C; Mazet R; Gallazzini C; Calizzano A; Vuillez JP; Allenet B; Fagret D
Ann Endocrinol (Paris); 2014 Sep; 75(4):241-6. PubMed ID: 25156133
[TBL] [Abstract][Full Text] [Related]
10. Radioiodine therapy of benign thyroid disorders: what are the effective thyroidal half-life and uptake of 131I?
Kobe C; Eschner W; Wild M; Rahlff I; Sudbrock F; Schmidt M; Dietlein M; Schicha H
Nucl Med Commun; 2010 Mar; 31(3):201-5. PubMed ID: 19907353
[TBL] [Abstract][Full Text] [Related]
11. [Radioiodine therapy of functional autonomy of the thyroid gland. Treatment results in view of pretreatment scintigraphic diagnosis and early response of triiodothyronine levels to treatment].
Langhammer HR; Laubenbacher C; Hirsch C; Klingele C; Spyra JL; Senekowitsch-Schmidtke R; Schwaiger M
Med Klin (Munich); 1999 Aug; 94(8):415-24. PubMed ID: 10495620
[TBL] [Abstract][Full Text] [Related]
12. [Commentary on the latest DGN procedure guidelines for radioiodine therapy for benign thyroid diseases].
Dietlein M; Drzezga A; Schmidt M
Nuklearmedizin; 2024 Feb; 63(1):4-7. PubMed ID: 37871627
[TBL] [Abstract][Full Text] [Related]
13. [Reduction of thyroid volume following radioiodine therapy for functional autonomy].
Luster M; Jacob M; Thelen MH; Michalowski U; Deutsch U; Reiners C
Nuklearmedizin; 1995 Apr; 34(2):57-60. PubMed ID: 7761274
[TBL] [Abstract][Full Text] [Related]
14. [Radioiodine therapy of benign thyroid disease in Denmark].
Rasmussen AK; Jarløv AE; Faber J
Ugeskr Laeger; 2000 Jan; 162(3):327-30. PubMed ID: 10680467
[TBL] [Abstract][Full Text] [Related]
15. Comments regarding Practice Recommendations of the American Thyroid Association for radiation safety in the treatment of thyroid disease with radioiodine.
Hennessey JV; Parker JA; Kennedy R; Garber JR
Thyroid; 2012 Mar; 22(3):336-7; author reply 337-8. PubMed ID: 22304332
[No Abstract] [Full Text] [Related]
16. Thyroid stunning in radioiodine-131 therapy of benign thyroid diseases.
Happel C; Kranert WT; Ackermann H; Binse I; Bockisch B; Gröner D; Herrmann K; Grünwald F
Endocrine; 2019 Mar; 63(3):537-544. PubMed ID: 30599051
[TBL] [Abstract][Full Text] [Related]
17. Influence of radioiodine therapy on urinary iodine excretion.
Meller B; Lauer I; Bähre M; Richter E
Nuklearmedizin; 1998 May; 37(3):107-12. PubMed ID: 9604231
[TBL] [Abstract][Full Text] [Related]
18. EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry II. Dosimetry prior to radioiodine therapy of benign thyroid diseases.
Hänscheid H; Canzi C; Eschner W; Flux G; Luster M; Strigari L; Lassmann M
Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):1126-34. PubMed ID: 23576099
[TBL] [Abstract][Full Text] [Related]
19. Comparing pre-therapeutic
Gühne F; Kühnel C; Freesmeyer M
Endocrine; 2017 Apr; 56(1):43-53. PubMed ID: 28271395
[TBL] [Abstract][Full Text] [Related]
20. [The importance of the radioiodine test for the calculation of the therapeutic dose in benign thyroid diseases].
Nüchel C; Boddenberg B; Schicha H
Nuklearmedizin; 1993 Apr; 32(2):91-8. PubMed ID: 8479936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
